Vanguard Group
OTLK icon

Vanguard Group’s Outlook Therapeutics OTLK Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$2M Buy
1,251,598
+414,191
+49% +$663K ﹤0.01% 3531
2025
Q1
$1.02M Sell
837,407
-15,133
-2% -$18.5K ﹤0.01% 3703
2024
Q4
$1.61M Sell
852,540
-3,336
-0.4% -$6.31K ﹤0.01% 3629
2024
Q3
$4.57M Buy
855,876
+308,103
+56% +$1.65M ﹤0.01% 3302
2024
Q2
$4.04M Buy
547,773
+206,473
+60% +$1.52M ﹤0.01% 3345
2024
Q1
$4.08M Sell
341,300
-6,219,100
-95% -$74.3M ﹤0.01% 3378
2023
Q4
$2.58M Buy
6,560,400
+277,326
+4% +$109K ﹤0.01% 3511
2023
Q3
$1.39M Buy
6,283,074
+134,946
+2% +$29.8K ﹤0.01% 3723
2023
Q2
$10.7M Buy
6,148,128
+137,591
+2% +$239K ﹤0.01% 2910
2023
Q1
$6.55M Buy
6,010,537
+347,876
+6% +$379K ﹤0.01% 3179
2022
Q4
$6.12M Buy
5,662,661
+45,255
+0.8% +$48.9K ﹤0.01% 3209
2022
Q3
$6.85M Sell
5,617,406
-2,230
-0% -$2.72K ﹤0.01% 3139
2022
Q2
$5.73M Sell
5,619,636
-16,483
-0.3% -$16.8K ﹤0.01% 3303
2022
Q1
$10M Sell
5,636,119
-331,130
-6% -$589K ﹤0.01% 3152
2021
Q4
$8.12M Buy
5,967,249
+1,227,070
+26% +$1.67M ﹤0.01% 3340
2021
Q3
$10.3M Buy
4,740,179
+105,769
+2% +$230K ﹤0.01% 3224
2021
Q2
$11.5M Buy
4,634,410
+469,128
+11% +$1.17M ﹤0.01% 3127
2021
Q1
$9.37M Buy
4,165,282
+1,835,651
+79% +$4.13M ﹤0.01% 3181
2020
Q4
$3.03M Buy
2,329,631
+1,652,994
+244% +$2.15M ﹤0.01% 3554
2020
Q3
$487K Buy
676,637
+140,377
+26% +$101K ﹤0.01% 3824
2020
Q2
$692K Buy
536,260
+7,080
+1% +$9.14K ﹤0.01% 3697
2020
Q1
$318K Buy
529,180
+212,427
+67% +$128K ﹤0.01% 3775
2019
Q4
$187K Sell
316,753
-162
-0.1% -$96 ﹤0.01% 3952
2019
Q3
$472K Sell
316,915
-79,086
-20% -$118K ﹤0.01% 3832
2019
Q2
$824K Buy
396,001
+347,238
+712% +$723K ﹤0.01% 3729
2019
Q1
$361K Sell
48,763
-340,036
-87% -$2.52M ﹤0.01% 3826
2018
Q4
$194K Sell
388,799
-184,006
-32% -$91.8K ﹤0.01% 3909
2018
Q3
$561K Buy
572,805
+263,768
+85% +$258K ﹤0.01% 3828
2018
Q2
$261K Sell
309,037
-3,670
-1% -$3.1K ﹤0.01% 3937
2018
Q1
$278K Buy
312,707
+7,440
+2% +$6.61K ﹤0.01% 3907
2017
Q4
$397K Hold
305,267
﹤0.01% 3798
2017
Q3
$418K Buy
305,267
+22,527
+8% +$30.8K ﹤0.01% 3783
2017
Q2
$285K Hold
282,740
﹤0.01% 3836
2017
Q1
$757K Buy
282,740
+3,467
+1% +$9.28K ﹤0.01% 3652
2016
Q4
$841K Buy
279,273
+186,158
+200% +$561K ﹤0.01% 3611
2016
Q3
$396K Buy
+93,115
New +$396K ﹤0.01% 3798